Kineticos AMR Accelerator Fund I Partners with Orthobond to Advance Medical Device Technologies

Wednesday, 11 September 2024, 22:00

Kineticos AMR Accelerator Fund I is investing in Orthobond to enhance innovations in medical devices. This partnership focuses on antibacterial surface technologies that can significantly impact the healthcare sector. With this collaboration, the potential for groundbreaking advancements in medical equipment applications is set to grow.
LivaRava_Medicine_Default.png
Kineticos AMR Accelerator Fund I Partners with Orthobond to Advance Medical Device Technologies

Kineticos AMR Accelerator Fund I Partners with Orthobond

Kineticos AMR Accelerator Fund I is excited to announce its collaboration with Orthobond, a prominent leader in covalently-bound antibacterial surface technologies. This investment marks a pivotal step toward advancing innovative medical devices within the healthcare industry.

Focus on Medical Device Innovations

Orthobond's technologies have extensive applications in the medical device sector, making this partnership instrumental in developing enhanced healthcare solutions. The Kineticos fund aims to drive research and innovation, ensuring that medical professionals have access to state-of-the-art equipment that meets emerging public health challenges.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe